F/M Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-36,004
Closed -$2.22M 414
2025
Q4
$2.22M Sell
36,004
-17,103
-32% -$1.05M 0.08% 227
2025
Q3
$3.31M Sell
53,107
-262
-0.5% -$18.2K 0.13% 179
2025
Q2
$4.26M Buy
53,369
+259
+0.5% +$21.7K 0.15% 140
2025
Q1
$4.57M Buy
53,110
+192
+0.4% +$15.7K 0.18% 119
2024
Q4
$4.13M Sell
52,918
-108,608
-67% -$8.43M 0.15% 140
2024
Q3
$11.6M Sell
161,526
-590
-0.4% -$41.8K 0.37% 83
2024
Q2
$11.2M Buy
+162,116
New +$11M 0.4% 70

Other funds holding PBH

F/M Investments's PBH Position: Q1 2026 in Review

F/M Investments sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 36,004 shares — an estimated $2.22M sold.

F/M Investments first reported a position in PBH in Q2 2024 and held it in 7 quarters. The position peaked at $11.6M in Q3 2024. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • F/M Investments reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • F/M Investments sold 36,004 Prestige Consumer Healthcare shares in Q1 2026, an estimated $2.22M.
  • F/M Investments first reported a position in Prestige Consumer Healthcare in Q2 2024 and held it in 7 quarters.
  • F/M Investments's Prestige Consumer Healthcare position peaked at $11.6M in Q3 2024.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.